AMGN vs. NVO: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and NVO, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
NVO stands out with 305.18 billion USD in market value—about 2.09× AMGN’s market cap of 145.90 billion USD.
AMGN’s beta of 0.50 points to much larger expected swings compared to NVO’s calmer 0.21, suggesting both higher upside and downside potential.
NVO is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike AMGN, which is purely domestic.
| Symbol | AMGN | NVO |
|---|---|---|
| Company Name | Amgen Inc. | Novo Nordisk A/S |
| Country | US | DK |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Robert A. Bradway | Mr. Lars Fruergaard Jorgensen |
| Price | 271.34 USD | 68.2 USD |
| Market Cap | 145.90 billion USD | 305.18 billion USD |
| Beta | 0.50 | 0.21 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 17, 1983 | April 30, 1981 |
| ADR | No | Yes |
Performance Comparison
This chart compares the performance of AMGN and NVO over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and NVO, please refer to the table below.
| Symbol | AMGN | NVO |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 18.78 |
| Forward PEG Ratio (TTM) | 7.08 | 1.31 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 6.53 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 14.18 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 26.50 |
| EV-to-EBITDA (TTM) | 15.71 | 12.81 |
| EV-to-Sales (TTM) | 5.70 | 6.80 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 27.57 |
Dividend Comparison
Both AMGN and NVO offer similar dividend yields (3.41% vs. 2.58%), indicating comparable approaches to balancing income and growth.
| Symbol | AMGN | NVO |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 2.58% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and NVO, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- NVO’s current ratio of 0.74 indicates its assets may not cover near-term debts, whereas AMGN at 1.17 maintains healthy liquidity.
- NVO posts a quick ratio of 0.56, indicating limited coverage of short-term debts from its most liquid assets—while AMGN at 0.88 enjoys stronger liquidity resilience.
- AMGN is heavily leveraged (debt-to-equity ratio 9.24), which can boost returns but raises risk if borrowing costs climb, while NVO at 0.86 keeps leverage at a more moderate level.
| Symbol | AMGN | NVO |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 0.74 |
| Quick Ratio (TTM) | 0.88 | 0.56 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 0.86 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.24 |
| Interest Coverage Ratio (TTM) | 3.19 | 17.84 |